WAVE Life Sciences (WVE) PT Lowered to $14 at RBC Capital
Tweet
Share
E-mailGet Alerts WVE Hot Sheet
Price: $5.41 +4.04%
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
RBC Capital analyst Luca Issi lowered the price target on WAVE Life Sciences (NASDAQ: WVE) to $14.00 (from $15.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Wave Life Sciences Announces Completion of Redomiciliation to Delaware
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
